Shockwave Stock Analysis


USD 243.11  6.02  2.54%   

The latest Shockwave Medical price fall created some momentum for sophisticated investors as it was traded today as low as 238.78 and as high as 250.16 per share. The company directors and management were unable to exploit market volatilities in November. However, diversifying your overall positions with Shockwave Medical can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.45. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Shockwave Medical partners.
Additionally, take a look at World Market Map.
The Shockwave Medical stock analysis report makes it easy to digest most publicly released information about Shockwave Medical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Shockwave Stock analysis module also helps to analyze the Shockwave Medical price relationship with some important fundamental indicators such as market cap and management efficiency.

Shockwave Stock Analysis Notes

About 93.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.38. Shockwave Medical had not issued any dividends in recent years. ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company was incorporated in 2009 and is headquartered in Santa Clara, California. Shockwave Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 657 people. To find out more about Shockwave Medical contact Douglas MBA at 510 279 4262 or learn more at

Shockwave Medical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Shockwave Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Shockwave Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Shockwave Medical generated a negative expected return over the last 90 days
Shockwave Medical has high historical volatility and very poor performance
The company reported the previous year's revenue of 237.15 M. Net Loss for the year was (9.14 M) with profit before overhead, payroll, taxes, and interest of 195.71 M.
Over 93.0% of the company shares are owned by institutional investors
Latest headline from Heres Why You Should Hold on to Nevro Stock Now - Nasdaq

Shockwave Medical Upcoming and Recent Events

Earnings reports are used by Shockwave Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Shockwave Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report17th of February 2022
Next Financial Report9th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End17th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Shockwave Largest EPS Surprises

Earnings surprises can significantly impact Shockwave Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Shockwave Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 9.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shockwave Medical's market, we take the total number of its shares issued and multiply it by Shockwave Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Shockwave Profitablity

Shockwave Medical's profitability indicators refer to fundamental financial ratios that showcase Shockwave Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Shockwave Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Shockwave Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Shockwave Medical's profitability requires more research than a typical breakdown of Shockwave Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.22 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.0.
Last ReportedProjected for 2022
Return on Investment(0.35) (0.37) 
Return on Average Assets(2.96) (3.19) 
Return on Average Equity(3.91) (4.22) 

Management Efficiency

The entity has return on total asset (ROA) of 0.1544 % which means that it generated profit of $0.1544 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 0.3055 %, meaning that it created $0.3055 on every $100 dollars invested by stockholders. Shockwave Medical management efficiency ratios could be used to measure how well shockwave medical manages its routine affairs as well as how well it operates its assets and liabilities. Return on Investment is likely to drop to -0.37 in 2022. Return on Average Assets is likely to drop to -3.19 in 2022. Shockwave Medical Total Assets are fairly stable at the moment as compared to the past year. Shockwave Medical reported Total Assets of 345.68 Million in 2021. Current Assets is likely to climb to about 308.5 M in 2022, whereas Return on Average Assets are likely to drop (3.19)  in 2022.

Technical Drivers

As of the 6th of December, Shockwave Medical has the risk adjusted performance of (0.1), and Coefficient Of Variation of (1,437). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Shockwave Medical, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Shockwave Medical, which can be compared to its competition. Please validate Shockwave Medical variance and potential upside to decide if Shockwave Medical is priced more or less accurately, providing market reflects its prevalent price of 243.11 per share. Given that Shockwave Medical has jensen alpha of (0.33), we advise you to double-check Shockwave Medical's current market performance to make sure the company can sustain itself at a future point.

Shockwave Medical Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Mid-point over period is an average of Shockwave Medical highest and lowest values attained during the given period.

Shockwave Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Shockwave Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Shockwave Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Shockwave Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Isaac Zacharias over a week ago via Macroaxis 
Exercise or conversion by Isaac Zacharias of 4000 shares of Shockwave Medical subject to Rule 16b-3
Zacharias Isaac over a month ago via Macroaxis 
Exercise or conversion by Zacharias Isaac of 1295 shares of Shockwave Medical subject to Rule 16b-3
Zacharias Isaac over a month ago via Macroaxis 
Exercise or conversion by Zacharias Isaac of 1295 shares of Shockwave Medical subject to Rule 16b-3
Zacharias Isaac over two months ago via Macroaxis 
Exercise or conversion by Zacharias Isaac of 4000 shares of Shockwave Medical subject to Rule 16b-3
Dan Puckett over two months ago via Macroaxis 
Exercise or conversion by Dan Puckett of 1100 shares of Shockwave Medical subject to Rule 16b-3
Watkins Frank T over two months ago via Macroaxis 
Sale by Watkins Frank T of 800 shares of Shockwave Medical
Zacharias Isaac over two months ago via Macroaxis 
Payment of 542 shares by Zacharias Isaac of Shockwave Medical subject to Rule 16b-3
Sainz Maria over two months ago via Macroaxis 
Sale by Sainz Maria of 650 shares of Shockwave Medical
Dan Puckett over three months ago via Macroaxis 
Exercise or conversion by Dan Puckett of 1100 shares of Shockwave Medical subject to Rule 16b-3
Antoine Papiernik over three months ago via Macroaxis 
Shockwave Medical exotic insider transaction detected
Godshall Douglas Evan over three months ago via Macroaxis 
Sale by Godshall Douglas Evan of 200 shares of Shockwave Medical
Zacharias Isaac over three months ago via Macroaxis 
Sale by Zacharias Isaac of 1300 shares of Shockwave Medical

Shockwave Medical Predictive Daily Indicators

Shockwave Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Shockwave Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Shockwave Medical Forecast Models

Shockwave Medical time-series forecasting models is one of many Shockwave Medical's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Shockwave Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Shockwave Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Shockwave Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Shockwave shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Shockwave Medical. By using and applying Shockwave Stock analysis, traders can create a robust methodology for identifying Shockwave entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin(0.37) (0.40) 
EBITDA Margin 0.91  0.98 
Gross Margin 82.53  89.04 
Profit Margin(3.85) (4.16) 

Current Shockwave Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Shockwave analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Shockwave analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Shockwave Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Shockwave analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Shockwave stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Shockwave Medical, talking to its executives and customers, or listening to Shockwave conference calls.
Shockwave Analyst Advice Details

Shockwave Stock Analysis Indicators

Shockwave Medical stock analysis indicators help investors evaluate how Shockwave Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Shockwave Medical shares will generate the highest return on investment. By understating and applying Shockwave Medical stock analysis, traders can identify Shockwave Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow51873000.00
Common Stock Shares Outstanding33088095.00
Total Stockholder Equity241830000.00
DescriptionShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and hea
Total Cashflows From Investing Activities26416000.00
Tax Provision301000.00
Quarterly Earnings Growth Y O Y17.4
Property Plant And Equipment Net51857000.00
Retained Earnings-252809000.00
Cash And Short Term Investments200981000.00
Retained Earnings Total Equity-252809000.00
Accounts Payable3520000.00
Net Debt-42020000.00
50 Day M A267.4391
Total Current Liabilities51628000.00
Currency CodeUSD
Other Operating Expenses238017000.00
Non Current Assets Total59780000.00
Forward Price Earnings69.9301
Common Stock Total Equity35000.00
Non Currrent Assets Other1936000.00
Additionally, take a look at World Market Map. Note that the Shockwave Medical information on this page should be used as a complementary analysis to other Shockwave Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Shockwave Stock analysis

When running Shockwave Medical price analysis, check to measure Shockwave Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shockwave Medical is operating at the current time. Most of Shockwave Medical's value examination focuses on studying past and present price action to predict the probability of Shockwave Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Shockwave Medical's price. Additionally, you may evaluate how the addition of Shockwave Medical to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
CEO Directory
Screen CEOs from public companies around the world
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Is Shockwave Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shockwave Medical. If investors know Shockwave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shockwave Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Shockwave Medical is measured differently than its book value, which is the value of Shockwave that is recorded on the company's balance sheet. Investors also form their own opinion of Shockwave Medical's value that differs from its market value or its book value, called intrinsic value, which is Shockwave Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shockwave Medical's market value can be influenced by many factors that don't directly affect Shockwave Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shockwave Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine Shockwave Medical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shockwave Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.